Company News

Dr. Chong Li
23
08 May 2026
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
97
29 Apr 2026
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
168
17 Apr 2026
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
376
24 Dec 2025
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
301
04 Dec 2025
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
334
27 Nov 2025
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
293
26 Nov 2025
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Dr. Chong Li
320
17 Nov 2025
Graduated from Fudan University,More than 20 years experience in Paclitaxel R&D and manufacturing.In 2015, established SGP to develop series of liposome technologies.
Categories: View More
Rigorous Standard
Stable Quality
Fast Delivery
Contact Us
Brand Network:
0
Inquire Basket
Empty
Inquiry
0
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept